- Home
- FTHM vs CRIS Comparison
FTHM vs CRIS Comparison
Compare FTHM & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- CRIS
- Stock Information
- Founded
- FTHM 2010
- CRIS 2000
- Country
- FTHM United States
- CRIS United States
- Employees
- FTHM N/A
- CRIS N/A
- Industry
- FTHM Real Estate
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FTHM Finance
- CRIS Health Care
- Exchange
- FTHM Nasdaq
- CRIS Nasdaq
- Market Cap
- FTHM 38.3M
- CRIS 22.9M
- IPO Year
- FTHM 2020
- CRIS 2000
- Fundamental
- Price
- FTHM $2.82
- CRIS $1.82
- Analyst Decision
- FTHM
- CRIS Strong Buy
- Analyst Count
- FTHM 0
- CRIS 2
- Target Price
- FTHM N/A
- CRIS $16.50
- AVG Volume (30 Days)
- FTHM 1.5M
- CRIS 75.5K
- Earning Date
- FTHM 11-06-2025
- CRIS 08-05-2025
- Dividend Yield
- FTHM N/A
- CRIS N/A
- EPS Growth
- FTHM N/A
- CRIS N/A
- EPS
- FTHM N/A
- CRIS N/A
- Revenue
- FTHM $390,032,000.00
- CRIS $11,405,000.00
- Revenue This Year
- FTHM $25.22
- CRIS $1.41
- Revenue Next Year
- FTHM $16.19
- CRIS $7.46
- P/E Ratio
- FTHM N/A
- CRIS N/A
- Revenue Growth
- FTHM 19.16
- CRIS 12.24
- 52 Week Low
- FTHM $0.65
- CRIS $1.02
- 52 Week High
- FTHM $3.37
- CRIS $6.44
- Technical
- Relative Strength Index (RSI)
- FTHM 70.20
- CRIS 57.41
- Support Level
- FTHM $1.80
- CRIS $1.63
- Resistance Level
- FTHM $2.98
- CRIS $1.95
- Average True Range (ATR)
- FTHM 0.45
- CRIS 0.14
- MACD
- FTHM 0.09
- CRIS 0.03
- Stochastic Oscillator
- FTHM 83.44
- CRIS 61.76
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.